Pliant Therapeutics Inc.
PLRX | NASDAQ
$0.86
$0.00 (0.00%)
At close: Oct 30, 2026, 4:00 PM ET
$0.85
-$0.01 (-1.16%)
After-hours:
Oct 30, 2026, 6:44 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 1.58M | 9.69M | 7.57M | 41.82M |
Cost of Revenue | 1.7M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -1.7M | n/a | 1.58M | 9.69M | 7.57M | 41.82M |
Operating Income | -150.07M | -228.37M | -184.15M | -127.2M | -97.54M | -41.65M |
Interest Income | n/a | 21.09M | 24.08M | 4.67M | 272K | 478K |
Pretax Income | -149.34M | -210.3M | -161.34M | -123.32M | -97.26M | -41.53M |
Net Income | -149.34M | -210.3M | -161.34M | -123.32M | -97.26M | -41.53M |
Selling & General & Admin | 47.22M | 59.06M | 57.93M | 39.95M | 27.56M | 17.27M |
Research & Development | 109.16M | 169.31M | 127.8M | 96.94M | 77.55M | 66.19M |
Other Expenses | -8M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 148.38M | 228.37M | 185.73M | 136.89M | 105.11M | 83.46M |
Interest Expense | 2.56M | 3.02M | 1.27M | 791K | n/a | 366K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 150.07M | 228.37M | 185.73M | 136.89M | 105.11M | 83.46M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 61.37M | 60.54M | 58.72M | 42.02M | 35.85M | 35.55M |
Shares Outstanding (Diluted) | 61.37M | 60.54M | 58.72M | 42.02M | 35.85M | 35.55M |
EPS (Basic) | -2.43 | -3.47 | -2.75 | -2.94 | -2.71 | -1.17 |
EPS (Diluted) | -2.43 | -3.47 | -2.75 | -2.94 | -2.71 | -1.17 |
EBITDA | -145.09M | -205.16M | -158.23M | -118.85M | -95.73M | -40.34M |
EBIT | -146.79M | -207.28M | -160.07M | -122.53M | -97.26M | -41.65M |
Depreciation & Amortization | 1.7M | 2.13M | 1.84M | 3.68M | 1.54M | 1.31M |
Add to Watchlist
Select watchlists to add or remove PLRX